This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Binkin, N. J. Articles by Koplan, J. P. Search for Related Content PubMed PubMed Citation Articles by Binkin, N. J. Articles by Koplan, J. P. Social Bookmarking                         What's this?

The High Cost and Low Efficacy of Weekly Viral Cultures for Pregnant Women with Recurrent Genital Herpes

A Reappraisal

Jeffrey P. Koplan, MD, MPH

The use of weekly cultures to prevent neonatal infection among infants of pregnant women who have histories of genital herpes has been controversial since a decision analysis study in 1983 suggested that this strategy was not cost-effective and would avert relatively few cases of neonatal herpes simplex virus infection. Using more recent and better data, the authors reanalyzed this approach to reducing neonatal herpes infection. The reanalysis revealed that a national screening program would prevent only 1.8 cases of neonatal herpes in the United States annually, at a cost of more than 37 million dollars per case averted. The program would cost nearly 7 million dollars per quality-adjusted life year gained when only infant deaths are taken into consideration. When maternal deaths from excess cesarean deliveries are taken into account, over 44 million dollars would be spent for every quality- adjusted life-year gained. On the basis of the strategy's limited benefits and low cost- effectiveness, the authors support the American College of Obstetrics and Gynecology's position of abandoning the recommendation for weekly prenatal herpes cultures. Key words: herpes; neonatal; screening; cost-effectiveness. (Med Decis Making 1989;9:225-230)

Medical Decision Making, Vol. 9, No. 4, 225-230 (1989)
DOI: 10.1177/0272989X8900900401


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. G. Randolph, A. E. Washington, and C. G. Prober Cesarean Delivery for Women Presenting With Genital Herpes Lesions: Efficacy, Risks, and Costs JAMA, July 7, 1993; 270(1): 77 - 82. [Abstract] [PDF]